Vor Biopharma Inc.VORNASDAQ
Loading
Year-over-year research & development expense growth
| Period | Value |
|---|---|
| Q3 2025 | -94.59% |
| Q2 2025 | 879.36% |
| Q1 2025 | 5.34% |
| Q4 2024 | 16.18% |
| Q3 2024 | -0.03% |
| Q2 2024 | -10.27% |
| Q1 2024 | 16.39% |
| Q4 2023 | -24.30% |
| Q3 2023 | 15.52% |
| Q2 2023 | 9.04% |
| Q1 2023 | 28.44% |
| Q4 2022 | 1.11% |
| Q3 2022 | 10.06% |
| Q2 2022 | 0.35% |
| Q1 2022 | 20.38% |
| Q4 2021 | -1.79% |
| Q3 2021 | -0.35% |
| Q2 2021 | 45.06% |
| Q1 2021 | -21.09% |
| Q4 2020 | 39.15% |
| Q3 2020 | 36.27% |
| Q2 2020 | -3.18% |
| Q1 2020 | 108.20% |
| Q4 2019 | 89.03% |
| Q3 2019 | 88.01% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |